Other Breast Cancer Experts
In addition to our Medical Advisory Board members, Living Beyond Breast Cancer is fortunate to have many other breast cancer experts who donate their time and energy to serve as speakers, reviewers, advocates and expert resources.
Dr. Nahabedian is the professor and vice chairman of the Department of Plastic Surgery at Georgetown University Hospital, in Washington DC.
Arpana Naik, MD, is a surgical oncologist and assistant professor at Oregon Health & Science University, where she is also medical director of the breast center.
Rita Nanda, MD, is an assistant professor of medicine and associate director of the Breast Medical Oncology Program at the University of Chicago School of Medicine
Hillary Nelson received her PhD in biochemistry from MIT and spent the next 25 years as a scientist, most recently as a professor at the University of Pennsylvania School of Medicine.
Dr. Newman is the director of the breast cancer center for the University of Michigan in Ann Arbor, where, as a surgical oncologist, she is also a professor of surgery.
Karen Neyer is assistant program director at the Cancer Support Community of Philadelphia (formerly The Wellness Community of Philadelphia), a nonprofit providing support, education and healthy lifestyle programs for people impacted by cancer.
Neal Niznan, LCSW, has more than 14 years of experience in oncology as a psychotherapist and social worker. He works in the department of radiation oncology at the Hospital of the University of Pennsylvania and has a private psychotherapy practice.
Ms. Noble is a licensed clinical social worker at the Kimmel Cancer Center at Thomas Jefferson University Hospital.
Judith Nudelman, MD, is a clinical associate professor of family medicine at the Alpert Medical School of Brown University in Providence, Rhode Island.
Ruth O’Regan, MD, is an associate professor of hematology and medical oncology and the director of the translational breast cancer research program at the Emory Winship Cancer Institute. Her research focuses on the differences in breast cancer subtypes in pre- and post-menopausal women and on triple-negative breast cancers in African-American women.